Table 1.
Study | Patients | Breasts | E (number) | DTI (number) | No. Implant Loss (%) | Necrosis, No Implant Loss (%) | Nicotine Necrosis |
---|---|---|---|---|---|---|---|
Carlson et al.2 (1997) | 68 | 68 | 0 | 68 | 0 | 18 (30) | 8 |
Hammond et al.3 (2002) | 8 | 12 | 10 | 2 | 1 (8.3) | 1 (8.3) | Unspecified |
Skoll and Hudson4 (2002) | 18 | 18 | 0 | 18 | 3 (0.16) | Unspecified | 1 |
Prathap and Harland5 (2004) | 6 | 6 | 0 | 6 | 0 | 0 | 0 |
della Rovere et al.6 (2008) | 10 | 18 | 18 | 0 | 1 (5.5) | 0 | 0 |
Nava et al.7 (2006) | 28 | 30 | 0 | 30 | 4 (13) | 0 | 3 |
Bayram et al.8 (2010) | 15 | 26 | 0 | 26 | 0 | 4 (15) | 1 |
Derderian et al.9 (2009) | 20 | Unspecified | 0 | 20 | 0 | 5 | 2 |
Ross10 (2012) | 10 | 20 | 0 | 20 | 0 | 1 (5) | 0 |
Losken et al.11 (2010) | 27 | 34 | 0 | 34 | 3 (8) | 4 (12) | Unspecified |
Colizzi et al.12 (2010) | 18 | 22 | 0 | 22 | 0 | 1 (4.5) | 1 |
Nair et al.13 (2010) | 72 | 89 | 55 | 34 | 2 (2) | 1 (1) | Unspecified |
Boneti et al.14 (2011) | 16 | Unspecified | 16 | Unspecified | Unspecified | Unspecified | |
Irwin et al.15 (2013) | 64 | 104 | 0 | 104 | 4 (3.8) | 10 (9.6) | Unspecified |
Dietz et al.16 (2012) | 43 | 43 | 43 | 0 | Unspecified | Unspecified | Unspecified |
Clerico et al.17 (2012) | 3 | 5 | 0 | 5 | 0 | 2 (40) | Unspecified |
Salgarello et al.18 (2012) | 14 | 16 | 0 | 16 | 1 (6.2) | 1 (6) | 0 |
Gentileschi et al.19 (2013) | 23 | 23 | 0 | 23 | 0 | 1 (4) | 1 |
Chang et al.20 (2013) | 6 | 11 | 0 | 11 | 0 | 1 (9) | Unspecified |
Ladizinsky et al.21 (2013) | 110 | 170 | 72 | 98 | 2 (1.2) | 26 (15) | Unspecified |
Demiri et al.22 (2017) | 50 | 65 | 65 | 0 | 4 (6.2) | 6 (9.2) | Unspecified |
Serrurier et al.23 (2017) | 45 | 80 | 0 | 80 | 2 (0.025) | Unspecified | Unspecified |
Santanelli et al.24 (2013) | 63 | 75 | 0 | 75 | 11 (1.3) | 9 (12) | 3 |
King et al.25 (2014) | 16 | 19 | 4 | 15 | 0 | 3 (16) | Unspecified |
DTI, direct to implant; E, expanders.